Synovial sarcoma: when epigenetic changes dictate tumour development
- PMID: 30506527
- DOI: 10.4414/smw.2018.14667
Synovial sarcoma: when epigenetic changes dictate tumour development
Abstract
Synovial sarcoma is a highly aggressive soft tissue malignancy that often affects adolescents and young adults. It is associated with a unique chromosomal translocation that results in the formation and expression of the fusion gene SS18-SSX, which underlies its pathogenesis. Although SS18-SSX provides a potentially unique therapeutic target, all attempts to neutralise it have been unsuccessful thus far. When complete surgical removal of the tumour fails, therapy is limited to largely ineffective cytotoxic drug regimens. Nevertheless, recent discoveries about the mechanisms of SS18-SSX protein function have provided insight into potential alternative therapeutic strategies. SS18-SSX displays oncogenic activity through protein-protein interactions and participation in chromatin remodelling complexes. This review summarises our current understanding of the function of SS18-SSX and the mechanisms by which it alters the epigenetic landscape of permissive cells to induce transformation and the subsequent development of synovial sarcoma.
Similar articles
-
Synovial Sarcoma: A Complex Disease with Multifaceted Signaling and Epigenetic Landscapes.Curr Oncol Rep. 2020 Oct 6;22(12):124. doi: 10.1007/s11912-020-00985-w. Curr Oncol Rep. 2020. PMID: 33025259 Review.
-
Synovial sarcoma is a gateway to the role of chromatin remodeling in cancer.Cancer Metastasis Rev. 2015 Sep;34(3):417-28. doi: 10.1007/s10555-015-9575-z. Cancer Metastasis Rev. 2015. PMID: 26277104 Review.
-
Truncated SSX protein suppresses synovial sarcoma cell proliferation by inhibiting the localization of SS18-SSX fusion protein.PLoS One. 2013 Oct 9;8(10):e77564. doi: 10.1371/journal.pone.0077564. eCollection 2013. PLoS One. 2013. PMID: 24130893 Free PMC article.
-
Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.Clin Orthop Relat Res. 2014 Mar;472(3):874-82. doi: 10.1007/s11999-013-3065-9. Clin Orthop Relat Res. 2014. PMID: 23716114 Free PMC article.
-
Molecular detection of SS18-SSX fusion gene transcripts by cRNA in situ hybridization in synovial sarcoma using formalin-fixed, paraffin-embedded tumor tissue specimens.Diagn Mol Pathol. 2007 Mar;16(1):9-17. doi: 10.1097/PDM.0b013e318031f02f. Diagn Mol Pathol. 2007. PMID: 17471153
Cited by
-
Identification of aberrantly methylated-differentially expressed genes and potential agents for Ewing sarcoma.Ann Transl Med. 2021 Oct;9(20):1557. doi: 10.21037/atm-21-4972. Ann Transl Med. 2021. PMID: 34790763 Free PMC article.
-
The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives.Curr Treat Options Oncol. 2021 Oct 23;22(12):109. doi: 10.1007/s11864-021-00914-4. Curr Treat Options Oncol. 2021. PMID: 34687366 Free PMC article. Review.
-
Identification of Potential Genomic Alterations and the circRNA-miRNA-mRNA Regulatory Network in Primary and Recurrent Synovial Sarcomas.Front Mol Biosci. 2021 Aug 13;8:707151. doi: 10.3389/fmolb.2021.707151. eCollection 2021. Front Mol Biosci. 2021. PMID: 34485383 Free PMC article.
-
The chromatin landscape of primary synovial sarcoma organoids is linked to specific epigenetic mechanisms and dependencies.Life Sci Alliance. 2020 Dec 23;4(2):e202000808. doi: 10.26508/lsa.202000808. Print 2021 Feb. Life Sci Alliance. 2020. PMID: 33361335 Free PMC article.
-
Birth Characteristics and Risk of Early-Onset Synovial Sarcoma.Cancer Epidemiol Biomarkers Prev. 2020 Jun;29(6):1162-1167. doi: 10.1158/1055-9965.EPI-20-0093. Epub 2020 Apr 3. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 32245786 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical